Global Market Access
Navigating Global Healthcare Markets with Syenza’s Expertise

Access Beyond Borders
We're inspired by dynamic and diverse global healthcare markets. As a leading value science company, Syenza supports market access activities with global intelligence and local understanding of pricing, reimbursement, and patients. Our philosophy is to drive efficiences through early engagement with payors and decision-makers to increase the probability of success.
Global Market Access Strategy
Outsourced Global Market Access
Value-based Contracting
Service Outcomes
Clients receive actionable insights
in Market Access Landscape Reports, Comparative Pricing Reports, and Value-Positioning Workshops.
Clients fill capacity gaps in market access organizations with EMAT to enhance launch and post-launch activities.
Clients apply in-market insights to develop value-based contracts that support access to innovations in different markets.
View Our Recent Case Study
Biopharmaceutical Market Access Analysis in Dubai
August 23, 2022
Objective : A market access landscape analysis is the first step to improving access in the target countries. This involved identifying the unmet need in the disease area, audiences with which to build a shared agenda, and shaping national reimbursem
Read More
View Our Recent Articles
Urgent Care Effectiveness: Exploring Canadian Centre...
🌟 Is urgent care the solution to easing pressure on our healthcare systems? In Canada, urgent care effectiveness is drawing attention as policymakers aim to enhance patient access and relieve overcrowded...
AI in Real-World Evidence: Insights from Mitch Hig...
🤖 How is AI reshaping Real-World Evidence and health technology assessments? In a recent Q&A with Dr. Mitch Higashi by Pharmalive, he dives into the transformative role of AI in healthcare, highlighting...
DTC Telehealth Partnerships: Navigating Risks in Pharma’s...
🚀 Are pharmaceutical companies' DTC telehealth partnerships reshaping healthcare for better or worse? Recent findings from the "DTC Investigation 2025" report reveal key insights into the high prescription...